Search
  • Reperio

SNN awards €18.000 to investigate the feasibility of eye movements tests in pediatric cerebral palsy

In absence of a shared "golden standard", Dystonic Cerebral Palsy can be difficult to correctly diagnose and distinguish from other forms of Pediatric Movement Disorders.


Eye movements are a very promising biomarker to support the phenotypization of these complex diseases.


Our goal at Reperio Medtech is to develop child-friendly tests that can help in the correct identification of the movement disorder in a completely non-invasive and stress-free manner.


If you would like to learn more, send us an email at info@reperio-medtech.com


139 views0 comments

Recent Posts

See All